CAR T-Cell Therapy and Bispecific Antibodies in Mantle Cell Lymphoma

被引：0
|
作者：
Kallam, Avyakta [1 ]
Danilov, Alexey [1 ]
Phillips, Tycel J. [1 ]
机构：
[1] City Hope Natl Med Ctr, 1500 E Duarte Rd, Duarte, CA 91010 USA
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
High risk; CRS; ICANS; bruton tyrosine kinase inhibitor; venetoclax;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S124 / S125
页数：2
相关论文
共 50 条
  • [21] CAR T-cell therapy for B-cell lymphoma
    Denlinger, Nathan
    Bond, David
    Jaglowski, Samantha
    CURRENT PROBLEMS IN CANCER, 2022, 46 (01)
  • [22] CAR T-cell therapy in large B cell lymphoma
    Boardman, Alexander P.
    Salles, Gilles
    HEMATOLOGICAL ONCOLOGY, 2023, 41 : 112 - 118
  • [23] TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma
    Vivian Changying Jiang
    Dapeng Hao
    Preetesh Jain
    Yijing Li
    Qingsong Cai
    Yixin Yao
    Lei Nie
    Yang Liu
    Jingling Jin
    Wei Wang
    Heng-Huan Lee
    Yuxuan Che
    Enyu Dai
    Guangchun Han
    Ruiping Wang
    Kunal Rai
    Andrew Futreal
    Christopher Flowers
    Linghua Wang
    Michael Wang
    Molecular Cancer, 21
  • [24] CAR-T Therapy Is Approved for Mantle Cell Lymphoma
    Voelker, Rebecca
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (09): : 832 - 832
  • [25] TIGIT is the central player in T-cell suppression associated with CAR T-cell relapse in mantle cell lymphoma
    Jiang, Vivian Changying
    Hao, Dapeng
    Jain, Preetesh
    Li, Yijing
    Cai, Qingsong
    Yao, Yixin
    Nie, Lei
    Liu, Yang
    Jin, Jingling
    Wang, Wei
    Lee, Heng-Huan
    Che, Yuxuan
    Dai, Enyu
    Han, Guangchun
    Wang, Ruiping
    Rai, Kunal
    Futreal, Andrew
    Flowers, Christopher
    Wang, Linghua
    Wang, Michael
    MOLECULAR CANCER, 2022, 21 (01)
  • [26] CAR T-cell therapy for lymphoma and multiple myeloma
    Kochenderfer, James N.
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [27] Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy
    Hamilton, Mark P.
    Sugio, Takeshi
    Noordenbos, Troy
    Shi, Shuyu
    Bulterys, Philip L.
    Liu, Chih Long
    Kang, Xiaoman
    Olsen, Mari N.
    Good, Zinaida
    Dahiya, Saurabh
    Frank, Matthew J.
    Sahaf, Bita
    Mackall, Crystal L.
    Gratzinger, Dita
    Diehn, Maximilian
    Alizadeh, Ash A.
    Miklos, David B.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (22): : 2047 - 2060
  • [28] Risk of Second Tumors and T-Cell Lymphoma after CAR T-Cell Therapy
    Godfrey, James
    Querfeld, Christiane
    Song, Joo
    Hamilton, Mark P.
    Miklos, David B.
    Alizadeh, Ash A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 391 (09): : 869 - 871
  • [29] Efficacy of CAR T-cell therapy is not impaired by previous bispecific antibody treatment in large B-cell lymphoma
    Crochet, Gilles
    Iacoboni, Gloria
    Couturier, Audrey
    Bachy, Emmanuel
    Iraola-Truchuelo, Josu
    Gastinne, Thomas
    Cartron, Guillaume
    Fradon, Tom
    Lesne, Bastien
    Kwon, Mi
    Gounot, Romain
    Martinez-Cibrian, Nuria
    Castilla-Llorente, Cristina
    Abrisqueta, Pau
    Guerreiro, Manuel
    Sarkozy, Clementine
    Aspa-Cilleruelo, Jose Maria
    Camus, Vincent
    Guidez, Stephanie
    Chauchet, Adrien
    Deconinck, Eric
    Bouabdallah, Krimo
    Bosch, Francesc
    Barba, Pere
    Morschhauser, Franck
    Houot, Roch
    BLOOD, 2024, 144 (03) : 334 - 338
  • [30] BTK Inhibitors and CAR T-Cell Therapy in Treating Mantle Cell Lymphoma-Finding a Dancing Partner
    Munoz, Javier L.
    Wang, Yucai
    Jain, Preetesh
    Wang, Michael
    CURRENT ONCOLOGY REPORTS, 2022, 24 (10) : 1299 - 1311
12345